Infliximab Therapy Impacts the Peripheral Immune System of Immunomodulator and Corticosteroid Naïve Patients with Crohn's Disease

BACKGROUND/AIMS: Infliximab (IFX), an antibody to tumor necrosis factor, (TNF)-α has efficacy in treating Crohn's disease (CD). However, knowledge of the potential effects of IFX on patients' immune profiles is lacking. The purpose of this study was to reveal the immunological effects of I...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kato, Kyoichi, Fukunaga, Ken, Kamikozuru, Koji, Kashiwamura, Shinichiro, Hida, Nobuyuki, Ohda, Yoshio, Takeda, Naohisa, Yoshida, Koji, Iimuro, Masaki, Yokoyama, Yoko, Kikuyama, Risa, Miwa, Hiroto, Matsumoto, Takayuki
Materialtyp: Artigo
Språk:Inglês
Publicerad: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases 2011
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3065091/
https://ncbi.nlm.nih.gov/pubmed/21461070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl.2011.5.1.37
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk